SODIUM CITRATE USP/PH.EUR PARENTEX
CAS Number
6132-04-3
Physical form
Powder
Product Description
pH modifier and buffering excipient for injectable formulations.
Benefits:
- Maintains low level of endotoxins with bioburden limits (BET and MLT) controlled as a part of specifications
- Metallic impurities controlled to suit the application
- Complies with USP and Ph.Eur specifications
- It is GMP and EXCiPACT certified
Key features
Parenteral Excipients
Dosage form
Injectable
Grade Name
SODIUM CITRATE USP/PH.EUR PARENTEX
chemical name
tri-Sodium citrate dihydrate
Categories pharma
Excipients > Injectable
Actylis
Actylis is a leading manufacturer and supplier of critical raw materials and performance ingredients serving the Life Sciences, Specialty Chemicals, and Agriscience industries.
